200 related articles for article (PubMed ID: 31958075)
1. LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression.
Cai X; Zhang X; Mo L; Zhu J; Yu H
Cancer Biomark; 2020; 27(4):493-504. PubMed ID: 31958075
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PCGEM1 enhances metastasis and gastric cancer invasion through targeting of miR-129-5p to regulate P4HA2 expression.
Zhang T; Piao HY; Guo S; Zhao Y; Wang Y; Zheng ZC; Zhang J
Exp Mol Pathol; 2020 Oct; 116():104487. PubMed ID: 32622013
[TBL] [Abstract][Full Text] [Related]
3. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
Chen S; Li K
BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR-433-3p and Targeting OMA1.
Li J; Zhang Y; Sun F; Zhang G; Pan XA; Zhou Q
Orthop Surg; 2023 Apr; 15(4):1060-1071. PubMed ID: 36782343
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
Weng L; Qiu K; Gao W; Shi C; Shu F
BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
[TBL] [Abstract][Full Text] [Related]
6. MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2.
Zhang H; Ye Q; Du Z; Huang M; Zhang M; Tan H
Biomed Pharmacother; 2018 Nov; 107():359-367. PubMed ID: 30099339
[TBL] [Abstract][Full Text] [Related]
7. LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
Duan H; Li X; Chen Y; Wang Y; Li Z
Life Sci; 2019 Dec; 239():116856. PubMed ID: 31525429
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PCGEM1 induces proliferation and migration in non-small cell lung cancer cells through modulating the miR-590-3p/SOX11 axis.
Wen H; Feng H; Ma Q; Liang C
BMC Pulm Med; 2021 Jul; 21(1):234. PubMed ID: 34261474
[TBL] [Abstract][Full Text] [Related]
9. LncRNA PCGsEM1 Contributes to the Proliferation, Migration and Invasion of Non-small Cell Lung Cancer Cells via acting as a Sponge for miR-152-3p.
Huang J; Lou J; Liu X; Xie Y
Curr Pharm Des; 2021; 27(46):4663-4670. PubMed ID: 34455968
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis.
Zhao J; Chen P; Tan C; Cheng X; Zhang W; Shen C; Zhang D
Aging (Albany NY); 2023 Oct; 15(19):10057-10071. PubMed ID: 37827696
[TBL] [Abstract][Full Text] [Related]
11. SNHG12 promotes carcinogenesis of human renal cell cancer via functioning as a competing endogenous RNA and sponging miR-30a-3p.
Yu H; Liu J; Zhang Z; Zhu Y; Bi J; Kong C
J Cell Mol Med; 2021 May; 25(10):4696-4708. PubMed ID: 33787057
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p.
Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W
Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156
[TBL] [Abstract][Full Text] [Related]
13. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
14. LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma.
Guo R; Zou B; Liang Y; Bian J; Xu J; Zhou Q; Zhang C; Chen T; Yang M; Wang H; Pei F; Xu Z
Cell Death Dis; 2021 Jul; 12(7):689. PubMed ID: 34244473
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
Yang Y; Dong MH; Hu HM; Min QH; Xiao L
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
[TBL] [Abstract][Full Text] [Related]
16. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
Wang Z; Chang X; Zhu G; Gao X; Chang L
Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
[TBL] [Abstract][Full Text] [Related]
17. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
19. The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma.
Li Q; Shen F; Zhao L
Biomed Pharmacother; 2018 Nov; 107():918-928. PubMed ID: 30257404
[TBL] [Abstract][Full Text] [Related]
20. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
